Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Science ; 330(6001): 222-5, 2010 Oct 08.
Article in English | MEDLINE | ID: mdl-20929774

ABSTRACT

Transgenic maize engineered to express insecticidal proteins from the bacterium Bacillus thuringiensis (Bt) has become widely adopted in U.S. agriculture. In 2009, Bt maize was planted on more than 22.2 million hectares, constituting 63% of the U.S. crop. Using statistical analysis of per capita growth rate estimates, we found that areawide suppression of the primary pest Ostrinia nubilalis (European corn borer) is associated with Bt maize use. Cumulative benefits over 14 years are an estimated $3.2 billion for maize growers in Illinois, Minnesota, and Wisconsin, with more than $2.4 billion of this total accruing to non-Bt maize growers. Comparable estimates for Iowa and Nebraska are $3.6 billion in total, with $1.9 billion for non-Bt maize growers. These results affirm theoretical predictions of pest population suppression and highlight economic incentives for growers to maintain non-Bt maize refugia for sustainable insect resistance management.


Subject(s)
Bacterial Proteins/genetics , Crops, Agricultural/economics , Endotoxins/genetics , Hemolysin Proteins/genetics , Moths , Pest Control, Biological , Zea mays/genetics , Animals , Bacillus thuringiensis/genetics , Bacillus thuringiensis Toxins , Crops, Agricultural/growth & development , Insecticide Resistance , Midwestern United States , Moths/physiology , Pest Control, Biological/economics , Pest Control, Biological/methods , Plants, Genetically Modified/growth & development , Population Density , Population Dynamics , Zea mays/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...